OptiNose
OPTN
$1.08
Share price
0.93%
Change (1 day)
-13.60%
Change (1 year)
Categories
OptiNose (OPTN) - Cash on Hand
Cash on Hand as of March 2024 : $51.64 M
According to OptiNose's latest financial reports the company has $51.64 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
OptiNose - Cash on Hand chart (from 2016 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $73.68 M | -21.82% |
| 2022-12-31 | $94.24 M | -14.71% |
| 2021-12-31 | $0.11 B | -23.35% |
| 2020-12-31 | $0.14 B | -2.03% |
| 2019-12-31 | $0.14 B | -26.79% |
| 2018-12-31 | $0.20 B | -14.42% |
| 2017-12-31 | $0.23 B | 538.24% |
| 2016-12-31 | $36.79 M | 142.12% |
| 2015-12-31 | $15.19 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $75.63 M | 46.46% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $16.39 M | -68.26% | 🇺🇸 USA |